IMGN
Immunogen Inc
IMGN
IMGN
Delisted
IMGN was delisted on the 9th of February, 2024.
327 hedge funds and large institutions have $7.66B invested in Immunogen Inc in 2023 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 71 increasing their positions, 101 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
19% more funds holding
Funds holding: 275 → 327 (+52)
30% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 101
Holders
327
Holding in Top 10
35
Calls
$225M
Puts
$138M
Top Buyers
| 1 | +$309M | |
| 2 | +$168M | |
| 3 | +$159M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$103M |
| 5 |
Morgan Stanley
New York
|
+$100M |
Top Sellers
| 1 | -$335M | |
| 2 | -$197M | |
| 3 | -$158M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$83.6M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$81M |